Cargando…
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
Persistence of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) under current antiviral therapy is a major barrier to eradication of chronic hepatitis B (CHB). Curing CHB will require novel strategies for specific disruption of cccDNA. The clustered regularly interspaced short palindr...
Autores principales: | Lin, Su-Ru, Yang, Hung-Chih, Kuo, Yi-Ting, Liu, Chun-Jen, Yang, Ta-Yu, Sung, Ku-Chun, Lin, You-Yu, Wang, Hurng-Yi, Wang, Chih-Chiang, Shen, Yueh-Chi, Wu, Fang-Yi, Kao, Jia-Horng, Chen, Ding-Shinn, Chen, Pei-Jer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221598/ https://www.ncbi.nlm.nih.gov/pubmed/25137139 http://dx.doi.org/10.1038/mtna.2014.38 |
Ejemplares similares
-
Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
por: Yang, Yu-Chan, et al.
Publicado: (2020) -
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
por: Horng, Jau-Hau, et al.
Publicado: (2020) -
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
por: Lin, Su-Ru, et al.
Publicado: (2021) -
Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
por: Yang, Yu-Chan, et al.
Publicado: (2021) -
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)